Identification and characterization of a novel chromosome-encoded aminoglycoside O-nucleotidyltransferase gene, ant(9)-Id, in Providencia sp. TYF-12 isolated from the marine fish intestine

Background: The mechanisms underlying the resistance of the genus Providencia to aminoglycosides are complex, which poses a challenge for the efficient treatment of infectious diseases caused by these pathogens. To help clinicians treat infections more effectively, a more comprehensive understanding of antibiotic resistance mechanisms is urgently needed.

Methods: Plates were streaked to isolate bacteria from the intestinal contents of fish. The standard agar dilution method was used to determine the minimum inhibitory concentrations (MICs) of the antimicrobial agents. Molecular cloning was carried out to study the function of the novel antibiotic inactivation gene ant(9)-Id. The kinetic parameters of ANT(9)-Id were measured by a SpectraMax multifunctional microplate reader. Whole-genome sequencing and bioinformatic analysis were conducted to elucidate the sequence structure and evolutionary relationships of similar genes.

Results: The novel aminoglycoside O-nucleotidyltransferase gene ant(9)-Id was encoded on the chromosome of a species-unclassified isolate designated Providencia sp. TYF-12, which was isolated from the intestine of a marine fish. Among the 11 aminoglycosides tested, ant(9)-Id was resistant to only spectinomycin. The MIC of spectinomycin for the recombinant strain carrying ant(9)-Id (pUCP20-ant(9)-Id/DH5α) increased 64-fold compared with that of the control strain (pUCP20/DH5ɑ). ANT(9)-Id shares the highest amino acid (aa) identity of 46.70% with the known drug resistance enzyme ANT(9)-Ic. Consistent with the MIC results, ANT(9)-Id showed high affinity and catalytic efficiency for spectinomycin, with a K_m of 8.94 ± 2.50 μM and a k_cat/K_m of 26.15 μM⁻¹·s⁻¹. This novel resistance gene and its close homologs are conserved in Providencia strains from various sources, including some of clinical significance. No mobile genetic elements (MGEs) surrounding the ant(9)-Id(−like) genes were identified.

Conclusion: This work revealed and characterized a novel spectinomycin resistance gene, ant(9)-Id, along with its biological features. Identifying novel resistance genes in pathogens can assist in rational medication use and the identification of additional antimicrobial resistance mechanisms in microbial populations.

Introduction

Providencia is a gram-negative bacillus within the family Enterobacteriaceae. The first described organism of this genus was Bacillus inconstans (Ornstein, 1920). During the period from 1943 to 1946, organisms of this genus were isolated from patients suffering from enteric diseases and were called “anaerogenic paracolon 29,911” (Stuart et al., 1943). In 1951, the genus Providencia was proposed, and this group of strains was therefore reclassified into the genus Providencia (O’Hara et al., 2000; Ovchinnikova et al., 2013). This genus currently contains 11 validly named members, such as P. rustigianii, P. heimbachae, and P. rettgeri, and three nonvalidly named species, namely, P. wenzhouensis (Zhou et al., 2021), P. hangzhouensis (Dong et al., 2023) and P. entomophila (Ksentini et al., 2019). These strains reside in polluted water reservoirs, wastewater and soil; they can also be isolated from living organisms and cause animal and human infections, and they can cause severe dyspnea and hemorrhagic pneumonia in piglets (Wang et al., 2014). These strains are also related to cholecystitis and hepatitis in domestic shorthair cats (Newton and Fry, 2018). As conditional pathogens, these strains can cause serious injections in humans, including meningitis and urinary tract infections (UTIs) (Sipahi et al., 2010). Procidencia spp. are the third most common cause of elderly urinary tract infections, next to Escherichia coli and Klebsiella spp. Globally (Vecchi et al., 2013). Among the Providencia genus, P. stuartii, P. hangzhouensis and P. rettgeri are significantly correlated with human infections (Dong et al., 2024).

Aminoglycoside antibiotics are broad-spectrum drugs that are mainly employed to treat suspected or confirmed acute serious infections (Serio et al., 2018). These antimicrobial agents exert bactericidal effects by attaching to the 16S rRNA within the target prokaryotic cell to halt the synthesis of bacterial proteins (Aradi et al., 2020; Doi et al., 2016). Resistance to aminoglycosides has become increasingly severe due to the abuse of antibiotics. The mechanisms underlying resistance to aminoglycosides include mainly aminoglycoside-modifying enzymes (AMEs) (Ramirez and Tolmasky, 2010), decreased antibiotic permeability (Donkor et al., 2023), increased endogenous drug efflux (Morita et al., 2012) and 16S rRNA methyltransferase activity (Kawai et al., 2021; Srinivas et al., 2023). Enzymatic modification is one of the most popular mechanisms leading to drug inactivation (Zárate et al., 2018). AMEs are divided into three families according to their modification positions: aminoglycoside N-acetyltransferases (AACs), aminoglycoside O-nucleotidyltransferases (ANTs), and aminoglycoside O-phosphotransferases (APHs). ANTs mediate drug inactivation by a nucleotide to a hydroxyl of the aminoglycoside (Ramirez and Tolmasky, 2010). Currently, there are five major categories of ANTs, including ANT(6), ANT(9), ANT(4′), ANT(3″) and ANT(2″), which catalyze hydroxyl group adenylation at corresponding positions. Because some Enterobacteriaceae, such as Providencia spp. Morganella morganii, can express high levels of AmpC beta-lactamases, which confer resistance to penicillin-like and cephalosporin antibiotics, the use of penicillins and cephalosporins should be avoided, and alternative therapy with aminoglycosides, quinolones or carbapenems is recommended (Harris and Ferguson, 2012; Liu et al., 2020).

In this study, through genomic sequencing and molecular cloning, an uncharacterized aminoglycoside O-nucleotidyltransferase gene, named ant(9)-Id, which was discovered in a Providencia isolate isolated from a marine fish intestine sample, was identified. The enzyme kinetic parameters of ANT(9)-Id were also studied.

Materials and methods

Bacterial strains and plasmids

In recent years, to investigate bacterial resistance to antimicrobials, more than 300 isolates have been isolated from marine samples in Wenzhou, Zhejiang Province, China. One isolate, designated Providencia sp. TYF-12, was obtained from a fish intestine. 16S RNA gene homology comparison, whole-genome average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) analyses were used for the identification of the bacteria. The strains and plasmids used in this study are listed in Table 1.

Table 1

Table 1. Bacteria and plasmids used in this work.

Antimicrobial susceptibility testing

In accordance with the standards of the Clinical and Laboratory Standards Institute (CLSI),¹ the agar dilution method was used to determine the minimum inhibitory concentration (MIC). E. coli ATCC 25922 served as a quality control for antibiotic susceptibility testing. The tested antimicrobial agents included spectinomycin, tobramycin, streptomycin, netilmicin, paromomycin and amikacin (Table 2).

Table 2

Table 2. MICs of 17 antimicrobials for 5 strains (μg/mL).

Sequencing and annotation of the genome sequences

The genomic DNA of Providencia sp. TYF-12 was sequenced on the Illumina HiSeq 2,500 and PacBio RS II platforms by Shanghai Personal Biotechnology Co., Ltd. (Shanghai, China). The long PacBio reads were first assembled via Unicycler (Wick et al., 2017) and then corrected with Illumina sequencing data via pilon (Walker et al., 2014). Prokka v1.14.6 (Seemann, 2014) was used for the prediction of the open reading frames (ORFs). Potential proteins were annotated via the NCBI nonredundant protein database and DIAMOND v2.0.11 (Buchfink et al., 2021). Antimicrobial resistance genes were predicted via Resistance Gene identifier v5.2.0² and the comprehensive antibiotic resistance database (CARD) (McArthur et al., 2013). The ANI was calculated via fastANI v1.33 (Jain et al., 2018). The genetic environment of ant(9)-Id and its homologous genes were analyzed via clinker v0.0.24 (Gilchrist and Chooi, 2021). The multiple sequence alignment diagram and phylogenetic tree were generated via MAFFT v7.490 and MEGAX (Katoh and Standley, 2013; Kumar et al., 2018), respectively. The molecular weight and pI of ANT(9)-Id were predicted via the JavaScript program (Stothard, 2000).

Molecular cloning of the resistance gene

The target gene, along with its promoter region, was amplified via PCR with the primers listed in Table 3. The PCR products were subsequently inserted into the pUCP20 vector via T4 DNA ligase (Takara Bio, Inc., Dalian, China). The recombinant plasmid was introduced into E. coli DH5α cells via the calcium transformation method, and the transformant were subsequently grown on Luria–Bertani (LB) solid media supplemented with ampicillin (AMP) at a final concentration of 100 μg/mL. The inserted sequence was confirmed via first-generation sequencing (Shanghai Sunny Biotechnology Co., Ltd., Shanghai, China).

Table 3

Table 3. Primers for cloning the ant(9)-Id gene.

Expression and purification of the recombinant protein ANT(9)-Id

To obtain the protein ANT(9)-Id, PCR was used for amplification of the ORF of the ant(9)-Id gene. The amplified product and the expression vector pCold I were both digested by the restriction enzymes BamHI and HindIII, and they were ligated. The recombinant plasmid (pCold I-ant(9)-Id) was transformed into E. coli BL21 cells. The transformants were screened on LB agar plates containing 100 μg/mL AMP, and the cloned fragment was verified by first-generation sequencing. The recombinant strain (E. coli BL21/pCold I-ant(9)-Id) was cultured overnight in LB broth supplemented with 100 μg/mL AMP at 37°C and then continuously cultured in LB liquid medium at a ratio of 1:100 until the optical density (OD₆₀₀) reached 0.6 to 0.8. Sterile isopropyl-beta-D-thiogalactopyranoside (IPTG; Sigma Chemicals Co., St. Louis, MO, United States) was added to a final concentration of 0.5 mM, and protein expression was induced in a shaker incubator at 16°C. The bacteria were collected by centrifugation (8,000 × g, 10 min) and then lysed by ultrasonication for 2 min, after which the supernatant was collected. The target protein in the supernatant was purified with a His-tag protein purification kit (Beyotime, Shanghai, China). At 25°C, the samples were treated with recombinant enterokinase (EK enzyme) for 2 h, after which the His-tag was removed. The purity and relative molecular mass of the enzyme were evaluated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). The protein concentration of ANT(9)-Id was determined via a BCA protein assay kit (Beyotime, Shanghai, China).

Kinetic studies of the enzyme ANT(9)-Id

The catalytic activity of ANT(9)-Id was analyzed by coupling the enzyme to UDP-glucose pyrophosphorylase (UGP), phosphoglucomutase (PGM) and glucose-6-phosphate dehydrogenase (G6PD). The increase in NADPH was measured at a wavelength of 340 nm via a SpectraMax multifunctional microplate reader (M5, Molecular Devices, America) to monitor the progress of the reaction. The total reaction system was 0.2 mL and contained a mixture of enzymes and substrates, including 2 U/mL UGP, 20 U/mL PGM, 20 U/mL G6PD, 10 mM MgCl₂, 50 mM HEPES (pH 7.5), 500 μM dithiothreitol (DTT), 500 μM UDP-glucose, 500 μM glucose 1,6-bisphosphate, 500 μM NADP, 2 mM ATP and purified ANT(9)-Id protein. The mixture was incubated at 37°C for 5 min, and a series of concentrations of spectinomycin were finally added to initiate the reaction. The enzyme kinetic parameters (k_cat and K_m) were determined by fitting the Michaelis–Menten equation via Prism (v8.0.2) software (Chen et al., 2019).

Results and discussion

Identification of potential novel aminoglycoside resistance genes

The MICs of the 11 antibiotics for the isolates were tested. Approximately 140 isolates with different resistance spectra were randomly selected (Supplementary Table S1), and the genome sequence of each isolate was sequenced on the Illumina HiSeq 2,500 platform. The potential resistance genes in these genomes were predicted (Supplementary Table S2). In this study, our attention was focused on uncovering aminoglycoside resistance mechanisms. According to the annotated antimicrobial resistance gene profiles derived from the genomic sequences of the 140 isolates, 11 prospective aminoglycoside resistance-related genes with <80% aa identity to the functionally characterized resistance genes in the CARD were selected, which included aadA9-, ant(9)-Ia-, aadA25-, aph(3′)-Ia-, aac(3)-Id-, aac(6′)-IIa-, aac(6′)-Ic-, aac(3)-Ia-, aac(3)-IV-, aac(2′)-Ia-, and aac(6′)-If-homologous genes. These genes were subsequently cloned, and their resistance phenotypes were tested. In vitro antimicrobial susceptibility testing revealed that the ant(9)-Ia-like gene (designated ant(9)-Id in this work) was functional.

ant(9)-Id confers resistance to spectinomycin

The novel resistance gene ant(9)-Id consists of 765 bp and encodes a protein of 254 aa (Supplementary Figure S1), which has a molecular weight of 28.67 kDa and an isoelectric point of 5.03. The results of the antimicrobial susceptibility test conducted on the recombinant strain (pUCP20-ant(9)-Id/DH5α) indicated that, of the 11 aminoglycosides tested, the strain demonstrated resistance to spectinomycin only. Compared with that of the control strain (pUCP20/DH5α), the MIC of spectinomycin (512 μg/mL) for the recombinant strain increased 64-fold. As we know that the vector pUCP20 is commonly used to analyze the function of a gene. As it is a high copy number plasmid, the in vivo protein concentration encoded by the cloned resistance gene (ant(9)-Id) in the recombinant (pUCP20-ant(9)-Id/DH5α) would be higher than that of the original host TYF-12 where the resistance gene is located in the chromosome which indicates that one cell has only one copy of the resistance gene. As a result, the MIC level increase of the recombinant carrying the cloned resistance gene (pUCP20-ant(9)-Id/DH5α) to an antimicrobial would be higher than that of the original host. The expression vector pCold I, however, was used to express the protein, so the MIC level of the recombinant (pCold I-ant(9)-Id/BL21) to the antimicrobial was not tested. As expected, the in vitro catalytic activity of ANT(9)-Id aligned with the in vivo MIC data of the ant(9)-Id gene. The enzyme selectively adenylates spectinomycin, with a K_m of 8.94 ± 2.50 μM and k_cat/K_m of 26.15 μM⁻¹·s⁻¹. However, no adenosine transfer effect on spectinomycin or tobramycin was observed (Table 4 and Supplementary Table S3).

Table 4

Table 4. Kinetic parameters of ANT(9)-Id.

The resistance characteristics of ant(9)-Id were consistent with those of the other ant(9) genes. At present, four ant(9) genes, namely, ant(9)-Ia (formerly named aad9 or spw), ant(9)-Ib, ant(9)-Ic and spd, are available in the CARD database. All of these strains were resistant to streptomycin only (Mahbub Alam et al., 2005; Murphy, 1985; LeBlanc et al., 1991; Sheng et al., 2023; Jamrozy et al., 2014; Wendlandt et al., 2013). Moreover, the proteins ANT(9)-Ib and ANT(9)-Ic also showed specific adenosine transfer effects on spectinomycin (Sheng et al., 2023).

The drug resistance phenotypes of the ANT family are diverse. ANT(9)s mediate resistance to spectinomycin alone (Mahbub Alam et al., 2005). ANT(6)s are resistant to streptomycin (Heo et al., 2022). ANT(3″)s confer resistance to both streptomycin and spectinomycin (Kehrenberg et al., 2005), whereas ANT(2″)s and ANT(4′)s adenylate multiple antimicrobial agents. ANT(2″)s are resistant to gentamicin, tobramycin, kanamycin and other aminoglycoside antibiotics (Wright and Serpersu, 2006); however, the presence of ANT(4′)s enables the host to be resistant to isepamicin, amikacin, tobramycin and other aminoglycoside antibiotics (Jacoby et al., 1990). AACs (Mayer, 1986) and APHs (Ramirez and Tolmasky, 2010) also have a wide substrate spectrum, except APH(9)s, which, like ANT(9)s, confer resistance to spectinomycin only (Fong et al., 2010).

Genome features, species classification and resistance characteristics of the isolate TYF-12

To investigate the molecular characteristics of the ant(9)-Id gene coding sequence, the entire genome of the isolate TYF-12, which carried the novel resistance gene, was sequenced. Free of a plasmid, the whole genome of TYF-12 contains a chromosome that is 4,660,160 bp in length, which encodes 4,613 coding sequences (CDSs) with an average GC content of 46.13% (Table 5).

Table 5

Table 5. General features of the Providencia sp. TYF-12 genome.

The 16S rRNA gene sequence of TYF-12 shared the closest relationship, with 99.47% identity and 98.0% coverage, with that of Providencia vermicola OP1 (NR_042415.1), followed by those of P. rettgeri DSM4541 (NR_042413.1, 99.27% identity and 96.0% coverage) and P. rettgeri NCTC11801 (NR_115880.1, 99.19% identity and 96.0% coverage). However, ANI analysis revealed that the genome of TYF-12 shared the greatest identity of 83.99% with that of P. rettgeri NCTC 11801 (GCF_900455085.1, not a type strain), followed by 81.6% with that of the type strain P. vermicola DSM 17385 (GCF_020381325.1). The dDDH analysis results were consistent with the ANI results, with the highest similarities of 53.3% with P. rettgeri NCTC11801 and 49.1% with P. vermicola DSM 17385. None of the genome sequences in the public database reached the threshold of ANI (96.0%) (Ciufo et al., 2018) or dDDH (70%) (Moore et al., 1987) for the classification of TYF-12 into an existing species. This finding indicated that this isolate represents a new species within the genus Providencia and was thus temporarily designated Providencia sp. TYF-12.

In addition to the novel resistance gene ant(9)-Id identified in this work, which encodes a protein with the highest aa similarity of 40.91% (87.6% coverage and 46.7% identity) with ANT(9)-Ic (QWQ57435.1) among the functionally characterized proteins, a total of 9 antimicrobial resistance genes with ≥80% nucleotide similarity to the functionally characterized genes found in the CARD database were identified from the whole genome, including two lincosamide genes (inuF and inuG), five aminoglycoside genes (aadA, aac(6′)-Ib-cr6, aph(3′)-Ia, aph(4)-Ia and aac(3)-IVa), one rifamycin (arr-3) and one macrolide (mphE) resistance gene (Supplementary Table S4). In vitro susceptibility analysis revealed that Providencia sp. TYF-12 was resistant to 5 (spectinomycin, streptomycin, kanamycin, paromomycin and ribostamycin) of the 17 antimicrobial agents tested. The aminoglycoside resistance phenotype was consistent with the genotype of the isolate (Supplementary Table S5).

Phylogenetic relationships and molecular characteristics of the ANT proteins

A phylogenetic tree of ANT(9)-Id with 34 other ANTs (containing 5 ANT(9)s and 29 ANT(3)s proteins with aa identity >30% with ANT(9)-Id) was reconstructed. At present, a total of 46 functionally characterized ANT family proteins are present in the CARD. They consisted of 2 ANT(2)s (4.35%, 2/46), 31 ANT(3)s (67.39%, 31/46), 4 ANT(4)s (8.70%, 4/46), 5 ANT(6)s (10.87%, 5/46) and 5 ANT(9)s (10.87%, 5/46). Among them, ANT(9)-Ic (QWQ57435.1) shared the highest aa similarity of 41.09% with ANT(9)-Id, followed by ANT(9)-Ia (CAA26428.1, 36.85%) and ANT(3)-Ib (QEQ43477.1, 34.08%), while the other sequences had similarities ranging from 29.64–34.03%. The phylogenetic tree shows that ANT(9)-Id has a close phylogenetic relationship with ANT(9)-Ia and ANT(9)-Ic; this further confirmed that the newly discovered resistance gene was indeed a member of the ANT(9) family (Figure 1).

Figure 1

Figure 1. Phylogenetic tree showing the relationships of ANT(9)-Id with other functionally characterized ANTs. ANT(9)-Id is highlighted with a red dot. Other ANTs include AadA (AAO49597.1), AadA2 (AAF27727.1), AadA3 (AAC14728.1), AadA4 (AAN34365.1), AadA5 (AAF17880.1), AadA6 (CAJ32504.1), AadA6/AadA10 (CAJ32491.1), AadA7 (BAD00739.1), AadA8 (AAN41439.1), AadA8b (CAJ13568.1), AadA9 (ABG49324.1), AadA10 (AAL36430.1), AadA11 (AAV32840.1), AadA12 (ACJ47200.1), AadA13 (ABW91178.1), AadA14 (CAI57696.1), AadA15 (ABD58917.1), AadA16 (ACF17980.1), AadA17 (ACK43806.1), AadA21 (AAN87151.1), AadA22 (CAK12750.1), AadA23 (CAH10847.1), AadA24 (ABG72894.1), AadA25 (AET15272.1), AadA27 (CTQ57092.1), ANT(3″)-Ib (QEQ43477.1), ANT(3″)-IIa (CAA26199.1), ANT(3″)-IIc (ENU37733.1), ANT(3″)-IIb (ENU91137.1), ANT(9)-Ia (CAA26428.1), ANT(9)-Ib (AAA16527.1), ANT(9)-Ic (QWQ57435.1), and Spd (AGW81558.1).

Multiple sequence alignment of ANT(9)-Id with its close relatives revealed that the functionally essential residues of the ANT(9) proteins were conserved in ANT(9)-Id. In AadA (Q8ZPX9), the amino acid residues W173 and D178 are highly important in the adenylation of streptomycin. In the case of spectinomycin, the essential amino acid residues E87, W112, D182 and either H185 or N185 play vital roles (Stern et al., 2018). The last four residues are conserved in ANT(9) family enzymes, including ANT(9)-Id (E82, W107, D174 and N177) (Figure 2).

Figure 2

Figure 2. Multiple sequence alignment of ANT(9)-Id with other relatives. Exclamations indicate fully conserved residues. Asterisks indicate strongly similar residues. Gaps are represented via hyphens. The numbers on the right represent the corresponding sequence length. The red frames indicate functional residues. The proteins are as follows: AadA, AadA2, AadA3, AadA4, AadA5, AadA6, AadA6/AadA10, AadA7, AadA8, AadA8b, AadA9, AadA10, AadA11, AadA12, AadA13, AadA14, AadA15, AadA16, AadA17, AadA21, AadA22, AadA23, AadA24, AadA25, AadA27, ANT(3″)-Ib, ANT(3″)-IIa, ANT(3″)-IIc, ANT(3″)-IIb, ANT(9)-Ia, ANT(9)-Ib, ANT(9)-Ic, and Spd. The accession numbers of the proteins are the same as those in Figure 1.

Distribution of ant(9)-Id-like genes

To analyze the distribution of the ant(9)-Id-like genes, the ANT(9)-Id amino acid sequence was used as a query to search for homologous proteins in the NCBI nonredundant protein database. A total of 14 hits that shared ≥99.21% similarity with ANT(9)-Id were identified, and all of them were derived from the genus Providencia (Supplementary Table S6). The amino acid sequence of the ANT(9)-Id protein was most similar (100.0%) to that of an aminoglycoside adenylyltransferase family protein (WP_129467149.1), whereas for the remaining 13 proteins, 10 and 3 shared 99.61 and 99.21% similarity, respectively (Figure 3). No protein sharing a similarity ranging from 99.21 to 70.0% was present. These 15 ant(9)-Id(−like) genes (including one from this work) were from bacteria of different sources. They were obtained mainly from human clinical samples (60.0%, 9/15). One of these samples was from marine fish (6.7%, 1/15); however, the sources of the other 5 samples were unknown (33.3%, 5/15) (Supplementary Table S6). Further analysis demonstrated that there were about 89 WP_129467149.1 proteins from the different Providencia species present in the database,² which included P. rettgeri, P. huashanensis, P. xianensis, P. alcalifaciens and several species-undefined strains. Different from the one of this work from the marine fish, the others were isolated from human clinical specimens, soil and so on (Supplementary Table S7).

Figure 3

Figure 3. Phylogenetic tree showing the relationships of ANT(9)-Id with other potential ANTs. ANT(9)-Id is highlighted with a red dot.

Analysis of the genetic context of the ant(9)-Id(−like) genes

To analyze the genetic background of the ant(9)-Id(−like) genes, the sequence approximately 20 kb in length with the ant(9)-Id gene at the center was intercepted and used as a query to search for similar sequences in the NCBI nucleotide database. Sixteen hits with similarities ranging from 99.37 to 99.72% (> 99.0% identity and 100.0% coverage) were retrieved, each of which encoded an ant(9)-Id(−like) gene. Among the 16 sequences, 62.5% (10/16) were from Providencia rettgeri, and the rest (37.5%, 6/16) were from species-unclassified Providencia strains (Supplementary Table S8). Except for these 16 sequences, no sequences shared ≥80% identity, and ≥ 80% coverage was found. Further structural analysis revealed that these fragments encoded genes related to the following functional categories: transcriptional regulator (lysR family), RidA/YER057c/UK114 superfamily protein, ferrous iron transport permease and so on. No mobile genetic element (MGE) was found within the fragments. These sequences exhibited high consistency in both gene content and gene order, which revealed that the ant(9)-Id(−like) gene-encoding sequences are highly conserved in the bacteria of the genus Providencia (Figure 4).

Figure 4

Figure 4. Genetic environment of the ant(9)-Id(−like) genes. Regions with ≥80.0% amino acid identity are colored gray. The ant(9)-Id(−like) genes are colored red. The accession numbers of the sequence sources are as follows: Providencia sp. PROV002 (CP096371.1), Providencia sp. PROV003 (CP096369.1), Providencia sp. PROV024 (CP120545.1), Providencia sp. PROV161 (CP096318.1), Providencia sp. PROV170 (CP096313.1), P. rettgeri 12,105 (CP109846.1), P. rettgeri FDAARGOS 1451 (CP077388.1), P. rettgeri PROV002 (CP059345.1), P. rettgeri L1 (CP087584.1), P. rettgeri YK205 (CP090217.1), P. rettgeri R39 (CP066315.1), P. rettgeri W986 (CP076258.1), P. rettgeri RB151 (CP017671.1), P. rettgeri FDAARGOS_330 (CP027418.1), and P. rettgeri HH18 (CP054158.1). hp, hypothetical protein; orfA, molybdopterin-dependent oxidoreductase; orfB, nucleotidyltransferase family protein; orfC, D-amino acid dehydrogenase; orfD, sodium/glutamate symporter; orfE, benzoylformate decarboxylase; orfF, adenine deaminase; orfG, amidohydrolase family protein; orfH, VWA domain-containing protein.

Conclusion

During this study, a novel aminoglycoside O-nucleotidyltransferase gene named ant(9)-Id was identified from the species-unclassified Providencia isolate TYF-12. As a gene of the ant(9) family, ant(9)-Id confers resistance to spectinomycin alone, and it shares the highest aa similarity with ant(9)-Ic. Genetic context analysis revealed that the ant(9)-Id(−like) genes are not related to a mobile genetic element and are conserved in the microbes of the genus Providencia, especially the species P. rettgeri. These findings indicate that this phenomenon might contribute to the intrinsic resistance mechanisms of the bacteria of Providencia. The discovery of a novel aminoglycoside O-nucleotidyltransferase gene, ant(9)-Id, can help us to further understand the distributions of the ant(9) family and the mechanisms of resistance in opportunistic clinical pathogens.

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.

Author contributions

YY: Writing – original draft, Writing – review & editing. RZ: Writing – review & editing. WP: Writing – review & editing. SC: Writing – review & editing. JW: Writing – review & editing. JL: Writing – review & editing. QB: Funding acquisition, Writing – review & editing. YH: Funding acquisition, Writing – review & editing. PJ: Funding acquisition, Writing – review & editing. DH: Writing – review & editing. XS: Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Science & Technology Project of Jinhua City, China (2023–3-159, 2022–2-013), the Science and Technology Plan Project of Taizhou (21ywb128), the Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2023KY1350) and the Science & Technology Project of Wenzhou City, China (N20210001).

Acknowledgments

The authors would like to acknowledge all the study participants and individuals who contributed to this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2024.1475172/full#supplementary-material

Footnotes

1. ^https://clsi.org

2. ^https://www.ncbi.nlm.nih.gov/protein/WP_129467149.1

References

Aradi, K., Di Giorgio, A., and Duca, M. (2020). Aminoglycoside conjugation for RNA targeting: antimicrobials and beyond. Chem A Eur J 26, 12273–12309. doi: 10.1002/chem.202002258

PubMed Abstract | Crossref Full Text | Google Scholar

Buchfink, B., Reuter, K., and Drost, H.-G. (2021). Sensitive protein alignments at tree-of-life scale using DIAMOND. Nat. Methods 18, 366–368. doi: 10.1038/s41592-021-01101-x

PubMed Abstract | Crossref Full Text | Google Scholar

Chen, Q., Zhou, W., Qian, C., Shen, K., Zhu, X., Zhou, D., et al. (2019). OXA-830, a novel chromosomally encoded extended-Spectrum class D β-lactamase in Aeromonas simiae. Front. Microbiol. 10:2732. doi: 10.3389/fmicb.2019.02732

Crossref Full Text | Google Scholar

Ciufo, S., Kannan, S., Sharma, S., Badretdin, A., Clark, K., Turner, S., et al. (2018). Using average nucleotide identity to improve taxonomic assignments in prokaryotic genomes at the NCBI. Int. J. Syst. Evol. Microbiol. 68, 2386–2392. doi: 10.1099/ijsem.0.002809

PubMed Abstract | Crossref Full Text | Google Scholar

Doi, Y., Wachino, J., and Arakawa, Y. (2016). Aminoglycoside Resistance. Infect. Dis. Clin. N. Am. 30, 523–537. doi: 10.1016/j.idc.2016.02.011

PubMed Abstract | Crossref Full Text | Google Scholar

Dong, X., Jia, H., Yu, Y., Xiang, Y., and Zhang, Y. (2024). Genomic revisitation and reclassification of the genus Providencia. mSphere 9, e00731–e00723. doi: 10.1128/msphere.00731-23

Crossref Full Text | Google Scholar

Dong, X., Yu, Y., Liu, J., Cao, D., Xiang, Y., Bi, K., et al. (2023). Whole-genome sequencing provides insights into a novel species: Providencia hangzhouensis associated with urinary tract infections. Microbiol Spectr 11, e01227–e01223. doi: 10.1128/spectrum.01227-23

Crossref Full Text | Google Scholar

Donkor, G. Y., Anderson, G. M., Stadler, M., Tawiah, P. O., Orellano, C. D., Edwards, K. A., et al. (2023). A novel ruthenium-silver based antimicrobial potentiates aminoglycoside activity against Pseudomonas aeruginosa. mSphere 8, e00190–e00123. doi: 10.1128/msphere.00190-23

Crossref Full Text | Google Scholar

Fong, D. H., Lemke, C. T., Hwang, J., Xiong, B., and Berghuis, A. M. (2010). Structure of the antibiotic resistance factor Spectinomycin phosphotransferase from Legionella pneumophila. J. Biol. Chem. 285, 9545–9555. doi: 10.1074/jbc.M109.038364

PubMed Abstract | Crossref Full Text | Google Scholar

Gilchrist, C. L. M., and Chooi, Y.-H. (2021). Clinker & clustermap.js: Automatic generation of gene cluster comparison figures.

Google Scholar

Harris, P. N. A., and Ferguson, J. K. (2012). Antibiotic therapy for inducible AmpC ␤-lactamase-producing gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int. J. Antimicrob. Agents. doi: 10.1016/j.ijantimicag.2012.06.004

PubMed Abstract | Crossref Full Text | Google Scholar

Heo, G., Kong, H., Kim, N., Lee, S., Sul, S., Jeong, D.-W., et al. (2022). Antibiotic susceptibility of Bacillus velezensis. FEMS Microbiol. Lett. 369:fnac017. doi: 10.1093/femsle/fnac017

Crossref Full Text | Google Scholar

Jacoby, G. A., Blaser, M. J., Santanam, P., Hächler, H., Kayser, F. H., Hare, R. S., et al. (1990). Appearance of amikacin and tobramycin resistance due to 4′-aminoglycoside nucleotidyltransferase [ANT(4′)-II] in gram-negative pathogens. Antimicrob. Agents Chemother. 34, 2381–2386. doi: 10.1128/AAC.34.12.2381

PubMed Abstract | Crossref Full Text | Google Scholar

Jain, C., Rodriguez-R, L. M., Phillippy, A. M., Konstantinidis, K. T., and Aluru, S. (2018). High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat. Commun. 9:5114. doi: 10.1038/s41467-018-07641-9

Crossref Full Text | Google Scholar

Jamrozy, D. M., Coldham, N. G., Butaye, P., and Fielder, M. D. (2014). Identification of a novel plasmid-associated spectinomycin adenyltransferase gene spd in methicillin-resistant Staphylococcus aureus ST398 isolated from animal and human sources. J. Antimicrob. Chemother. 69, 1193–1196. doi: 10.1093/jac/dkt510

PubMed Abstract | Crossref Full Text | Google Scholar

Katoh, K., and Standley, D. M. (2013). MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780. doi: 10.1093/molbev/mst010

PubMed Abstract | Crossref Full Text | Google Scholar

Kawai, A., Suzuki, M., Tsukamoto, K., Minato, Y., and Doi, Y. (2021). Functional and structural characterization of acquired 16S rRNA methyltransferase NpmB1 conferring Pan-aminoglycoside resistance. Antimicrob. Agents Chemother. 65, e01009–e01021. doi: 10.1128/AAC.01009-21

Crossref Full Text | Google Scholar

Kehrenberg, C., Catry, B., Haesebrouck, F., De Kruif, A., and Schwarz, S. (2005). Novel Spectinomycin/streptomycin resistance gene, aadA14, from Pasteurella multocida. Antimicrob. Agents Chemother. 49, 3046–3049. doi: 10.1128/AAC.49.7.3046-3049.2005

PubMed Abstract | Crossref Full Text | Google Scholar

Ksentini, I., Gharsallah, H., Sahnoun, M., Schuster, C., Hamli Amri, S., Gargouri, R., et al. (2019). Providencia entomophila sp. nov., a new bacterial species associated with major olive pests in Tunisia. PLoS One 14:e0223943. doi: 10.1371/journal.pone.0223943

PubMed Abstract | Crossref Full Text | Google Scholar

Kumar, S., Stecher, G., Li, M., Knyaz, C., and Tamura, K. (2018). MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547–1549. doi: 10.1093/molbev/msy096

PubMed Abstract | Crossref Full Text | Google Scholar

LeBlanc, D. J., Lee, L. N., and Inamine, J. M. (1991). Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis. Antimicrob. Agents Chemother. 35, 1804–1810. doi: 10.1128/AAC.35.9.1804

PubMed Abstract | Crossref Full Text | Google Scholar

Liu, J., Wang, R., and Fang, M. (2020). Clinical and drug resistance characteristics of Providencia stuartii infections in 76 patients. J. Int. Med. Res.

Google Scholar

Mahbub Alam, M., Kobayashi, N., Ishino, M., Sumi, A., Kobayashi, K.-I., Uehara, N., et al. (2005). Detection of a novel aph(2″) allele (aph[2″]-Ie) conferring high-level gentamicin resistance and a Spectinomycin resistance gene ant(9)-Ia (aad9) in clinical isolates of enterococci. Microb. Drug Resist. 11, 239–247. doi: 10.1089/mdr.2005.11.239

PubMed Abstract | Crossref Full Text | Google Scholar

Mayer, K. H. (1986). Review of epidemic aminoglycoside resistance worldwide. Am. J. Med. 80, 56–64. doi: 10.1016/0002-9343(86)90480-8

PubMed Abstract | Crossref Full Text | Google Scholar

McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad, M. A., Baylay, A. J., et al. (2013). The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57, 3348–3357. doi: 10.1128/AAC.00419-13

PubMed Abstract | Crossref Full Text | Google Scholar

Moore, W. E. C., Stackebrandt, E., Kandler, O., Colwell, R. R., Krichevsky, M. I., Truper, H. G., et al. (1987). Report of the ad hoc committee on reconciliation of approaches to bacterial systematics. Int. J. Syst. Evol. Microbiol. 37, 463–464. doi: 10.1099/00207713-37-4-463

Crossref Full Text | Google Scholar

Morita, Y., Tomida, J., and Kawamura, Y. (2012). Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7. Microbiology 158, 1071–1083. doi: 10.1099/mic.0.054320-0

PubMed Abstract | Crossref Full Text | Google Scholar

Murphy, E. (1985). Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3″) (9). Mol. Gen. Genet. 200, 33–39. doi: 10.1007/BF00383309

PubMed Abstract | Crossref Full Text | Google Scholar

Newton, P. L., and Fry, D. R. (2018). Successful treatment of Providencia rettgeri cholecystitis and neutrophilic cholangitis in a cat. J Feline Med Surg Open Reports 4:205511691775076. doi: 10.1177/2055116917750763

Crossref Full Text | Google Scholar

O’Hara, C. M., Brenner, F. W., and Miller, J. M. (2000). Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin. Microbiol. Rev. 13, 534–546. doi: 10.1128/CMR.13.4.534

Crossref Full Text | Google Scholar

Ornstein, M. (1920). Zur bakteriologie des schmitzbazillus. Z Hyg. 91, 152–178.

Google Scholar

Ovchinnikova, O. G., Rozalski, A., Liu, B., and Knirel, Y. A. (2013). O-antigens of bacteria of the genus Providencia: structure, serology, genetics, and biosynthesis. Biochemistry Moscow 78, 798–817. doi: 10.1134/S0006297913070110

PubMed Abstract | Crossref Full Text | Google Scholar

Ramirez, M. S., and Tolmasky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151–171. doi: 10.1016/j.drup.2010.08.003

PubMed Abstract | Crossref Full Text | Google Scholar

Seemann, T. (2014). Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069. doi: 10.1093/bioinformatics/btu153

PubMed Abstract | Crossref Full Text | Google Scholar

Serio, A. W., Keepers, T., Andrews, L., and Krause, K. M. (2018). Aminoglycoside revival: review of a historically important class of antimicrobials undergoing rejuvenation. EcoSal Plus 8:1. doi: 10.1128/ecosalplus.esp-0002-2018

PubMed Abstract | Crossref Full Text | Google Scholar

Sheng, X., Lu, W., Li, A., Lu, J., Song, C., Xu, J., et al. (2023). ANT(9)-Ic, a novel chromosomally encoded aminoglycoside Nucleotidyltransferase from Brucella intermedia. Microbiol Spectr 11, e00620–e00623. doi: 10.1128/spectrum.00620-23

Crossref Full Text | Google Scholar

Sipahi, O. R., Bardak-Ozcem, S., Ozgiray, E., Aydemir, S., Yurtseven, T., Yamazhan, T., et al. (2010). Meningitis due to Providencia stuartii. J. Clin. Microbiol. 48, 4667–4668. doi: 10.1128/JCM.01349-10

PubMed Abstract | Crossref Full Text | Google Scholar

Srinivas, P., Nosrati, M., Zelinskaya, N., Dey, D., Comstock, L. R., Dunham, C. M., et al. (2023). 30S subunit recognition and G1405 modification by the aminoglycoside-resistance 16S ribosomal RNA methyltransferase RmtC. Proc. Natl. Acad. Sci. USA 120:e2304128120. doi: 10.1073/pnas.2304128120

PubMed Abstract | Crossref Full Text | Google Scholar

Stern, A. L., Van Der Verren, S. E., Kanchugal, P. S., Näsvall, J., Gutiérrez-de-Terán, H., and Selmer, M. (2018). Structural mechanism of AadA, a dual-specificity aminoglycoside adenylyltransferase from Salmonella enterica. J. Biol. Chem. 293, 11481–11490. doi: 10.1074/jbc.RA118.003989

PubMed Abstract | Crossref Full Text | Google Scholar

Stothard, P. (2000). The sequence manipulation suite: Java script programs for analyzing and formatting protein and DNA sequences. Bio Techniques 28, 1102–1104. doi: 10.2144/00286ir01

Crossref Full Text | Google Scholar

Stuart, C. A., Wheeler, K. M., Rustigian, R., and Zimmerman, A. (1943). Biochemical and antigenic relationships of the Paracolon Bacteria. J. Bacteriol. 45, 101–119. doi: 10.1128/jb.45.2.101-119.1943

PubMed Abstract | Crossref Full Text | Google Scholar

Vecchi, E. D., Sitia, S., Romano, C. L., Ricci, C., Mattina, R., and Drago, L. (2013). Aetiology and antibiotic resistance patterns of urinary tract infections in the elderly: a 6-month study. J. Med. Microbiol. 62, 859–863. doi: 10.1099/jmm.0.056945-0

Crossref Full Text | Google Scholar

Walker, B. J., Abeel, T., Shea, T., Priest, M., Abouelliel, A., Sakthikumar, S., et al. (2014). Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 9:e112963. doi: 10.1371/journal.pone.0112963

PubMed Abstract | Crossref Full Text | Google Scholar

Wang, X., Wang, J., Hao, H., Qiu, L., Liu, H., Chen, S., et al. (2014). Pathogenic Providencia alcalifaciens strain that causes fatal hemorrhagic pneumonia in piglets. Curr. Microbiol. 68, 278–284. doi: 10.1007/s00284-013-0470-y

PubMed Abstract | Crossref Full Text | Google Scholar

Wendlandt, S., Li, B., Lozano, C., Ma, Z., Torres, C., and Schwarz, S. (2013). Identification of the novel spectinomycin resistance gene spw in methicillin-resistant and methicillin-susceptible Staphylococcus aureus of human and animal origin. J. Antimicrob. Chemother. 68, 1679–1680. doi: 10.1093/jac/dkt081

PubMed Abstract | Crossref Full Text | Google Scholar

Wick, R. R., Judd, L. M., Gorrie, C. L., and Holt, K. E. (2017). Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13:e1005595. doi: 10.1371/journal.pcbi.1005595

PubMed Abstract | Crossref Full Text | Google Scholar

Wright, E., and Serpersu, E. H. (2006). Molecular determinants of affinity for aminoglycoside binding to the aminoglycoside Nucleotidyltransferase (2″)-Ia. Biochemistry 45, 10243–10250. doi: 10.1021/bi060935d

PubMed Abstract | Crossref Full Text | Google Scholar

Zárate, S., De La Cruz Claure, M., Benito-Arenas, R., Revuelta, J., Santana, A., and Bastida, A. (2018). Overcoming aminoglycoside enzymatic resistance: Design of Novel Antibiotics and Inhibitors. Molecules 23:284. doi: 10.3390/molecules23020284

PubMed Abstract | Crossref Full Text | Google Scholar

Zhou, K., Liang, J., Dong, X., Zhang, P., Feng, C., Shi, W., et al. (2021). Identification and characterization of a novel chromosomal aminoglycoside 2′-N-acetyltransferase, AAC(2′)-if, from an isolate of a novel Providencia species, Providencia wenzhouensis R33. Front. Microbiol. 12:711037. doi: 10.3389/fmicb.2021.711037

PubMed Abstract | Crossref Full Text | Google Scholar